Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine

Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions

(2012) V. Doceul et al.   JOURNAL OF GENERAL VIROLOGY

The Soluble Serum Protein Gas6 Bridges Virion Envelope Phosphatidylserine to the TAM Receptor Tyrosine Kinase Axl to Mediate Viral Entry

(2011) Kouki Morizono et al.   Cell Host & Microbe

Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture

(2011) Florian Ingo Schmidt et al.   EMBO JOURNAL

Immune complement activation is attenuated by surface nanotopography

(2011) Mats Hulander et al.   International Journal of Nanomedicine

Serological responses in humans to the smallpox vaccine LC16m8

(2011) B. F. Johnson et al.   JOURNAL OF GENERAL VIROLOGY

Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors

(2011) Matthew E. Cohen et al.   PLoS One

The Membrane Fusion Step of Vaccinia Virus Entry Is Cooperatively Mediated by Multiple Viral Proteins and Host Cell Components

(2011) Jason P. Laliberte et al.   PLoS Pathogens

A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus

(2011) Kimberly A. Dowd et al.   PLoS Pathogens

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model

(2010) Megan M McCausland et al.   ANTIVIRAL THERAPY

Smallpox vaccines: targets of protective immunity

(2010) Bernard Moss   IMMUNOLOGICAL REVIEWS

Poxvirus Complement Control Proteins Are Expressed on the Cell Surface through an Intermolecular Disulfide Bridge with the Viral A56 Protein

(2010) B. C. DeHaven et al.   JOURNAL OF VIROLOGY

Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry

(2010) J. Mercer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread

(2010) V. Doceul et al.   SCIENCE

Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus

(2010) Xiangzhi Meng et al.   VIROLOGY

Lipid Membranes in Poxvirus Replication

(2010) Jason P. Laliberte et al.   Viruses-Basel

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

(2009) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246

(2009) J. Huggins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

(2009) Erin Mehlhop et al.   Cell Host & Microbe

Cloning and expression of murine Ig genes from single B cells

(2009) Thomas Tiller et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The Structure of the Poxvirus A33 Protein Reveals a Dimer of Unique C-Type Lectin-Like Domains

(2009) H.-P. Su et al.   JOURNAL OF VIROLOGY

Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5

(2009) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

(2009) Kenneth Smith et al.   Nature Protocols

Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry

(2009) J. P. Laliberte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The smallpox vaccine induces an early neutralizing IgM response

(2009) Juan E. Moyron-Quiroz et al.   VACCINE

Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism

(2009) Erin Mehlhop et al.   VIROLOGY

An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies

(2008) Xiaocong Yu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack

(2008) N. M. Girgis et al.   JOURNAL OF VIROLOGY

Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

(2008) Gunilla B. Karlsson Hedestam et al.   NATURE REVIEWS MICROBIOLOGY

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

(2008) X. Brochet et al.   NUCLEIC ACIDS RESEARCH

Vaccinia Virus Uses Macropinocytosis and Apoptotic Mimicry to Enter Host Cells

(2008) J. Mercer et al.   SCIENCE

Toward an AIDS Vaccine

(2008) B. D. Walker et al.   SCIENCE

Vaccinia virus morphogenesis and dissemination

(2008) Kim L. Roberts et al.   TRENDS IN MICROBIOLOGY

Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus

(2008) John B. Johnson et al.   VIROLOGY

Surviving Mousepox Infection Requires the Complement System

(2008) Elizabeth A. Moulton et al.   PLoS Pathogens

Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge

(2007) Kathleen A. Marriott et al.   VACCINE